Cambridge Cognition (LON:COG – Get Free Report) issued its quarterly earnings data on Monday. The company reported GBX (3.90) earnings per share for the quarter, Digital Look Earnings reports. Cambridge Cognition had a negative return on equity of 58.72% and a negative net margin of 18.47%.The business had revenue of GBX 940 million during the quarter.
Cambridge Cognition Price Performance
COG stock opened at GBX 40 on Tuesday. The company has a debt-to-equity ratio of 63.61, a current ratio of 0.39 and a quick ratio of 0.96. Cambridge Cognition has a 1 year low of GBX 23.90 and a 1 year high of GBX 45. The firm has a 50-day moving average of GBX 39.61 and a 200 day moving average of GBX 34.52. The company has a market cap of £18.62 million, a P/E ratio of -10.53 and a beta of 0.83.
Analysts Set New Price Targets
Separately, Panmure Gordon reaffirmed a “buy” rating and issued a GBX 56 price target on shares of Cambridge Cognition in a research note on Monday, January 19th. One investment analyst has rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of GBX 56.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
See Also
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
